An adenosine-sensitive adenylate cyclase has been demonstrated in anterior pituitary cultured cells in the present studies. N-ethylcarboxamideadenosine (NECA), L-N6-phenylisopropyladenosine (PIA), and 5’-N-methylcarbox-amideadenosine (MECA), all stimulated adenylate cyclase in a concentration-dependent manner in the order of potency NECA> PIA> MECA. Adenosine showed a biphasic effect on adenylate cyclase: stimulation at lower and inhibition at higher concentrations, whereas 2’-deoxyadenosine only inhibited adenylate cyclase in a concentration-dependent manner. The stimulatory effect of NECA on adenylate cyclase was dependent on metal ion concentrations and was blocked by 3-isobutyl-1-methylxanthine and 8-phenyltheophylline. Various agonists such as isoproterenol, prostaglandins (PGE1), vasoactive intestinal peptide, corticotropin-releasing factor, NaF, and forskolin, all stimulated adenylate cyclase to various degrees. The stimulatory effect of vasoactive intestinal peptide and corticotropin-releasing factor on adenylate cyclase was found to be almost additive with the stimulation exerted by NECA. These data indicate the presence of adenosine stimulatory receptors (‘Ra’) in anterior pituitary which are coupled to adenylate cyclase. It is possible that adenosine may act as one of the important regulators to regulate and/or modulate the effects of agents/factors in the release of pituitary hormones.

Keywords:
Adenosine, Adenylate cyclase, Anterior pituitary, Receptors, Methylxanthines, Corticotropin-releasing factor, Vasoactive intestinal peptide, Forskolin, Prostaglandins
This content is only available via PDF.
© 1985 S. Karger AG, Basel
1985
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.